TSS
SGTX

Two Sigma Securities’s Sigilon Therapeutics, Inc. Common Stock SGTX Stock Holding History

Two Sigma Securities’s Portfolio SGTX Stock Details SGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,272
Closed -$8K – 3454
2022
Q3 		$8K Sell
1,272
-100
-7% -$913 ﹤0.01% 2436
2022
Q2 		$15K Buy
+1,372
New +$18.4K ﹤0.01% 1995

Other funds holding SGTX

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $2.32B AUM 30.12% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Two Sigma Securities's SGTX Position: Q4 2022 in Review

Two Sigma Securities sold out of Sigilon Therapeutics, Inc. Common Stock (SGTX) in Q4 2022, closing a stake of 1,272 shares — an estimated $8K sold.

Two Sigma Securities first reported a position in SGTX in Q2 2022 and held it in 2 quarters. The position peaked at $15K in Q2 2022. 32 funds tracked by Wall St. Rank hold SGTX as of Q4 2022.

  • Two Sigma Securities reported no remaining Sigilon Therapeutics, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Two Sigma Securities sold 1,272 Sigilon Therapeutics, Inc. Common Stock shares in Q4 2022, an estimated $8K.
  • Two Sigma Securities first reported a position in Sigilon Therapeutics, Inc. Common Stock in Q2 2022 and held it in 2 quarters.
  • Two Sigma Securities's Sigilon Therapeutics, Inc. Common Stock position peaked at $15K in Q2 2022.
  • 32 funds tracked by Wall St. Rank held Sigilon Therapeutics, Inc. Common Stock as of Q4 2022.

Based on Two Sigma Securities's 13F filing for Q4 2022, filed 14 Feb 2023.